nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—Telmisartan—coronary artery disease	0.107	0.304	CrCtD
Candesartan—AGTR1—coronary artery disease	0.105	1	CbGaD
Candesartan—Olmesartan—coronary artery disease	0.0884	0.252	CrCtD
Candesartan—Valsartan—coronary artery disease	0.0843	0.24	CrCtD
Candesartan—Losartan—coronary artery disease	0.0717	0.204	CrCtD
Candesartan—AGTR1—Olmesartan—coronary artery disease	0.0288	0.131	CbGbCtD
Candesartan—AGTR1—Telmisartan—coronary artery disease	0.023	0.105	CbGbCtD
Candesartan—AGTR1—Valsartan—coronary artery disease	0.0224	0.102	CbGbCtD
Candesartan—Deferasirox—Telmisartan—coronary artery disease	0.0155	0.0652	CrCrCtD
Candesartan—Azilsartan medoxomil—Telmisartan—coronary artery disease	0.0155	0.0652	CrCrCtD
Candesartan—UGT1A3—Pitavastatin—coronary artery disease	0.0143	0.065	CbGbCtD
Candesartan—AGTR1—Losartan—coronary artery disease	0.0129	0.0586	CbGbCtD
Candesartan—Azilsartan medoxomil—Olmesartan—coronary artery disease	0.0128	0.054	CrCrCtD
Candesartan—Telmisartan—Olmesartan—coronary artery disease	0.0128	0.054	CrCrCtD
Candesartan—Forasartan—Olmesartan—coronary artery disease	0.0111	0.0467	CrCrCtD
Candesartan—Valsartan—Olmesartan—coronary artery disease	0.0111	0.0467	CrCrCtD
Candesartan—Irbesartan—Olmesartan—coronary artery disease	0.0111	0.0467	CrCrCtD
Candesartan—Olmesartan—Telmisartan—coronary artery disease	0.0106	0.0448	CrCrCtD
Candesartan—Forasartan—Valsartan—coronary artery disease	0.0106	0.0445	CrCrCtD
Candesartan—Irbesartan—Valsartan—coronary artery disease	0.0106	0.0445	CrCrCtD
Candesartan—UGT1A3—Ezetimibe—coronary artery disease	0.0105	0.0479	CbGbCtD
Candesartan—Telmisartan—Losartan—coronary artery disease	0.0104	0.0438	CrCrCtD
Candesartan—Azilsartan medoxomil—Losartan—coronary artery disease	0.0104	0.0438	CrCrCtD
Candesartan—Tasosartan—Olmesartan—coronary artery disease	0.00979	0.0413	CrCrCtD
Candesartan—UGT1A3—Simvastatin—coronary artery disease	0.00978	0.0446	CbGbCtD
Candesartan—Losartan—Telmisartan—coronary artery disease	0.00966	0.0407	CrCrCtD
Candesartan—UGT1A3—Lovastatin—coronary artery disease	0.00957	0.0436	CbGbCtD
Candesartan—Tasosartan—Valsartan—coronary artery disease	0.00934	0.0394	CrCrCtD
Candesartan—Forasartan—Losartan—coronary artery disease	0.00898	0.0379	CrCrCtD
Candesartan—Valsartan—Losartan—coronary artery disease	0.00898	0.0379	CrCrCtD
Candesartan—Irbesartan—Losartan—coronary artery disease	0.00898	0.0379	CrCrCtD
Candesartan—UGT1A3—Atorvastatin—coronary artery disease	0.00872	0.0397	CbGbCtD
Candesartan—Olmesartan—Valsartan—coronary artery disease	0.00839	0.0354	CrCrCtD
Candesartan—Losartan—Olmesartan—coronary artery disease	0.00801	0.0338	CrCrCtD
Candesartan—UGT1A3—Losartan—coronary artery disease	0.00798	0.0363	CbGbCtD
Candesartan—Tasosartan—Losartan—coronary artery disease	0.00794	0.0335	CrCrCtD
Candesartan—Losartan—Valsartan—coronary artery disease	0.00764	0.0322	CrCrCtD
Candesartan—Olmesartan—Losartan—coronary artery disease	0.00714	0.0301	CrCrCtD
Candesartan—CYP2C8—Fenofibrate—coronary artery disease	0.00431	0.0197	CbGbCtD
Candesartan—CYP2C8—Gemfibrozil—coronary artery disease	0.00345	0.0157	CbGbCtD
Candesartan—ABCB1—Ticagrelor—coronary artery disease	0.00328	0.0149	CbGbCtD
Candesartan—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00325	0.0148	CbGbCtD
Candesartan—CYP2C9—Fenofibrate—coronary artery disease	0.00301	0.0137	CbGbCtD
Candesartan—CYP2C8—Clopidogrel—coronary artery disease	0.00299	0.0136	CbGbCtD
Candesartan—CYP2C8—Pitavastatin—coronary artery disease	0.00261	0.0119	CbGbCtD
Candesartan—CYP2C9—Gemfibrozil—coronary artery disease	0.00241	0.011	CbGbCtD
Candesartan—CYP2C9—Clopidogrel—coronary artery disease	0.00209	0.0095	CbGbCtD
Candesartan—ABCB1—Perindopril—coronary artery disease	0.00202	0.00922	CbGbCtD
Candesartan—ABCB1—Clopidogrel—coronary artery disease	0.00202	0.00922	CbGbCtD
Candesartan—CYP2C9—cardial valve—coronary artery disease	0.00202	0.323	CbGeAlD
Candesartan—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00188	0.00855	CbGbCtD
Candesartan—CYP2C9—Pitavastatin—coronary artery disease	0.00182	0.0083	CbGbCtD
Candesartan—CYP2C8—Simvastatin—coronary artery disease	0.00179	0.00816	CbGbCtD
Candesartan—CYP2C9—Valsartan—coronary artery disease	0.00177	0.00808	CbGbCtD
Candesartan—ABCB1—Telmisartan—coronary artery disease	0.00177	0.00806	CbGbCtD
Candesartan—ABCB1—Pitavastatin—coronary artery disease	0.00177	0.00806	CbGbCtD
Candesartan—CYP2C8—Pravastatin—coronary artery disease	0.00175	0.00799	CbGbCtD
Candesartan—CYP2C8—Lovastatin—coronary artery disease	0.00175	0.00799	CbGbCtD
Candesartan—ABCB1—Enalapril—coronary artery disease	0.00168	0.00764	CbGbCtD
Candesartan—ABCB1—Lisinopril—coronary artery disease	0.00168	0.00764	CbGbCtD
Candesartan—CYP2C8—Atorvastatin—coronary artery disease	0.0016	0.00727	CbGbCtD
Candesartan—CYP2C8—Losartan—coronary artery disease	0.00146	0.00665	CbGbCtD
Candesartan—ABCB1—Timolol—coronary artery disease	0.00143	0.0065	CbGbCtD
Candesartan—CYP2C9—Rosuvastatin—coronary artery disease	0.00134	0.00612	CbGbCtD
Candesartan—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00131	0.00597	CbGbCtD
Candesartan—ABCB1—Ezetimibe—coronary artery disease	0.0013	0.00594	CbGbCtD
Candesartan—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00127	0.00579	CbGbCtD
Candesartan—ABCB1—Captopril—coronary artery disease	0.00126	0.00572	CbGbCtD
Candesartan—CYP2C9—Simvastatin—coronary artery disease	0.00125	0.00569	CbGbCtD
Candesartan—CYP2C9—Pravastatin—coronary artery disease	0.00122	0.00557	CbGbCtD
Candesartan—CYP2C9—Lovastatin—coronary artery disease	0.00122	0.00557	CbGbCtD
Candesartan—ABCB1—Simvastatin—coronary artery disease	0.00121	0.00552	CbGbCtD
Candesartan—ABCB1—Lovastatin—coronary artery disease	0.00119	0.00541	CbGbCtD
Candesartan—ABCB1—Pravastatin—coronary artery disease	0.00119	0.00541	CbGbCtD
Candesartan—CYP2C9—Atorvastatin—coronary artery disease	0.00111	0.00507	CbGbCtD
Candesartan—ABCB1—Atorvastatin—coronary artery disease	0.00108	0.00492	CbGbCtD
Candesartan—CYP2C9—Losartan—coronary artery disease	0.00102	0.00464	CbGbCtD
Candesartan—ABCB1—Losartan—coronary artery disease	0.000988	0.0045	CbGbCtD
Candesartan—AGTR1—artery—coronary artery disease	0.000628	0.101	CbGeAlD
Candesartan—AGTR1—endothelium—coronary artery disease	0.00053	0.0849	CbGeAlD
Candesartan—AGTR1—cardiac ventricle—coronary artery disease	0.000352	0.0564	CbGeAlD
Candesartan—AGTR1—myocardium—coronary artery disease	0.000331	0.053	CbGeAlD
Candesartan—PTGS1—artery—coronary artery disease	0.000276	0.0442	CbGeAlD
Candesartan—Azilsartan medoxomil—AGTR1—coronary artery disease	0.000234	0.158	CrCbGaD
Candesartan—PTGS1—endothelium—coronary artery disease	0.000233	0.0373	CbGeAlD
Candesartan—AGTR1—heart—coronary artery disease	0.000231	0.037	CbGeAlD
Candesartan—AGTR1—cardiovascular system—coronary artery disease	0.000218	0.0349	CbGeAlD
Candesartan—Forasartan—AGTR1—coronary artery disease	0.000217	0.147	CrCbGaD
Candesartan—AGTR1—cardiac atrium—coronary artery disease	0.000198	0.0317	CbGeAlD
Candesartan—AGTR1—blood—coronary artery disease	0.000173	0.0276	CbGeAlD
Candesartan—PTGS1—myocardium—coronary artery disease	0.000146	0.0233	CbGeAlD
Candesartan—Tasosartan—AGTR1—coronary artery disease	0.000132	0.0893	CrCbGaD
Candesartan—Irbesartan—EDNRA—coronary artery disease	0.00013	0.0879	CrCbGaD
Candesartan—Valsartan—AGTR1—coronary artery disease	0.000114	0.0774	CrCbGaD
Candesartan—CYP2C9—heart—coronary artery disease	0.000111	0.0178	CbGeAlD
Candesartan—Olmesartan—AGTR1—coronary artery disease	0.000111	0.0754	CrCbGaD
Candesartan—Telmisartan—AGTR1—coronary artery disease	0.000107	0.0728	CrCbGaD
Candesartan—CYP2C9—cardiovascular system—coronary artery disease	0.000105	0.0168	CbGeAlD
Candesartan—PTGS1—heart—coronary artery disease	0.000102	0.0163	CbGeAlD
Candesartan—PTGS1—cardiovascular system—coronary artery disease	9.6e-05	0.0154	CbGeAlD
Candesartan—CYP2C8—blood—coronary artery disease	9.36e-05	0.015	CbGeAlD
Candesartan—PTGS1—cardiac atrium—coronary artery disease	8.7e-05	0.0139	CbGeAlD
Candesartan—Irbesartan—AGTR1—coronary artery disease	8.64e-05	0.0587	CrCbGaD
Candesartan—CYP2C9—blood—coronary artery disease	8.31e-05	0.0133	CbGeAlD
Candesartan—Pranlukast—TNF—coronary artery disease	7.83e-05	0.0531	CrCbGaD
Candesartan—PTGS1—blood—coronary artery disease	7.59e-05	0.0121	CbGeAlD
Candesartan—Telmisartan—PPARG—coronary artery disease	6.75e-05	0.0458	CrCbGaD
Candesartan—ABCB1—heart—coronary artery disease	6.01e-05	0.00962	CbGeAlD
Candesartan—ABCB1—cardiovascular system—coronary artery disease	5.67e-05	0.00908	CbGeAlD
Candesartan—Losartan—AGTR1—coronary artery disease	5.57e-05	0.0378	CrCbGaD
Candesartan—Telmisartan—CYP2C19—coronary artery disease	4.58e-05	0.0311	CrCbGaD
Candesartan—ABCB1—blood—coronary artery disease	4.49e-05	0.00718	CbGeAlD
Candesartan—Losartan—ACE—coronary artery disease	3.22e-05	0.0218	CrCbGaD
Candesartan—Valsartan—ALB—coronary artery disease	2.7e-05	0.0183	CrCbGaD
Candesartan—Dizziness—Ezetimibe—coronary artery disease	2.38e-05	0.000446	CcSEcCtD
Candesartan—Palpitations—Timolol—coronary artery disease	2.38e-05	0.000446	CcSEcCtD
Candesartan—Losartan—CYP2C19—coronary artery disease	2.38e-05	0.0161	CrCbGaD
Candesartan—Abdominal pain—Enalapril—coronary artery disease	2.38e-05	0.000445	CcSEcCtD
Candesartan—Body temperature increased—Enalapril—coronary artery disease	2.38e-05	0.000445	CcSEcCtD
Candesartan—Rash—Fenofibrate—coronary artery disease	2.37e-05	0.000444	CcSEcCtD
Candesartan—Dermatitis—Fenofibrate—coronary artery disease	2.37e-05	0.000444	CcSEcCtD
Candesartan—Headache—Fenofibrate—coronary artery disease	2.36e-05	0.000441	CcSEcCtD
Candesartan—Paraesthesia—Losartan—coronary artery disease	2.36e-05	0.000441	CcSEcCtD
Candesartan—Gastrointestinal pain—Captopril—coronary artery disease	2.36e-05	0.000441	CcSEcCtD
Candesartan—Urticaria—Telmisartan—coronary artery disease	2.35e-05	0.000441	CcSEcCtD
Candesartan—Cough—Timolol—coronary artery disease	2.35e-05	0.00044	CcSEcCtD
Candesartan—Vomiting—Clopidogrel—coronary artery disease	2.35e-05	0.00044	CcSEcCtD
Candesartan—Diarrhoea—Simvastatin—coronary artery disease	2.35e-05	0.00044	CcSEcCtD
Candesartan—Gastrointestinal disorder—Furosemide—coronary artery disease	2.35e-05	0.00044	CcSEcCtD
Candesartan—Myalgia—Ramipril—coronary artery disease	2.35e-05	0.000439	CcSEcCtD
Candesartan—Arthralgia—Ramipril—coronary artery disease	2.35e-05	0.000439	CcSEcCtD
Candesartan—Chest pain—Ramipril—coronary artery disease	2.35e-05	0.000439	CcSEcCtD
Candesartan—Fatigue—Furosemide—coronary artery disease	2.34e-05	0.000439	CcSEcCtD
Candesartan—Abdominal pain—Telmisartan—coronary artery disease	2.34e-05	0.000439	CcSEcCtD
Candesartan—Body temperature increased—Telmisartan—coronary artery disease	2.34e-05	0.000439	CcSEcCtD
Candesartan—Dyspnoea—Losartan—coronary artery disease	2.34e-05	0.000438	CcSEcCtD
Candesartan—Anxiety—Ramipril—coronary artery disease	2.34e-05	0.000438	CcSEcCtD
Candesartan—Vomiting—Lovastatin—coronary artery disease	2.34e-05	0.000437	CcSEcCtD
Candesartan—Somnolence—Losartan—coronary artery disease	2.33e-05	0.000437	CcSEcCtD
Candesartan—Dizziness—Eplerenone—coronary artery disease	2.33e-05	0.000437	CcSEcCtD
Candesartan—Rash—Clopidogrel—coronary artery disease	2.33e-05	0.000436	CcSEcCtD
Candesartan—Dermatitis—Clopidogrel—coronary artery disease	2.33e-05	0.000436	CcSEcCtD
Candesartan—Asthenia—Valsartan—coronary artery disease	2.33e-05	0.000436	CcSEcCtD
Candesartan—Hypertension—Timolol—coronary artery disease	2.33e-05	0.000436	CcSEcCtD
Candesartan—Asthenia—Olmesartan—coronary artery disease	2.32e-05	0.000434	CcSEcCtD
Candesartan—Headache—Clopidogrel—coronary artery disease	2.32e-05	0.000434	CcSEcCtD
Candesartan—Rash—Lovastatin—coronary artery disease	2.32e-05	0.000434	CcSEcCtD
Candesartan—Dermatitis—Lovastatin—coronary artery disease	2.31e-05	0.000433	CcSEcCtD
Candesartan—Anaemia—Lisinopril—coronary artery disease	2.31e-05	0.000433	CcSEcCtD
Candesartan—Dyspepsia—Losartan—coronary artery disease	2.31e-05	0.000432	CcSEcCtD
Candesartan—Headache—Lovastatin—coronary artery disease	2.3e-05	0.000431	CcSEcCtD
Candesartan—Pruritus—Valsartan—coronary artery disease	2.3e-05	0.00043	CcSEcCtD
Candesartan—Chest pain—Timolol—coronary artery disease	2.29e-05	0.00043	CcSEcCtD
Candesartan—Arthralgia—Timolol—coronary artery disease	2.29e-05	0.00043	CcSEcCtD
Candesartan—Myalgia—Timolol—coronary artery disease	2.29e-05	0.00043	CcSEcCtD
Candesartan—Vomiting—Ezetimibe—coronary artery disease	2.29e-05	0.000429	CcSEcCtD
Candesartan—Gastrointestinal pain—Perindopril—coronary artery disease	2.29e-05	0.000428	CcSEcCtD
Candesartan—Anxiety—Timolol—coronary artery disease	2.29e-05	0.000428	CcSEcCtD
Candesartan—Angioedema—Lisinopril—coronary artery disease	2.28e-05	0.000428	CcSEcCtD
Candesartan—Pruritus—Olmesartan—coronary artery disease	2.28e-05	0.000428	CcSEcCtD
Candesartan—Body temperature increased—Captopril—coronary artery disease	2.28e-05	0.000426	CcSEcCtD
Candesartan—Abdominal pain—Captopril—coronary artery disease	2.28e-05	0.000426	CcSEcCtD
Candesartan—Dizziness—Simvastatin—coronary artery disease	2.27e-05	0.000425	CcSEcCtD
Candesartan—Rash—Ezetimibe—coronary artery disease	2.27e-05	0.000425	CcSEcCtD
Candesartan—Dermatitis—Ezetimibe—coronary artery disease	2.27e-05	0.000425	CcSEcCtD
Candesartan—Asthenia—Niacin—coronary artery disease	2.26e-05	0.000424	CcSEcCtD
Candesartan—Fatigue—Losartan—coronary artery disease	2.26e-05	0.000424	CcSEcCtD
Candesartan—Headache—Ezetimibe—coronary artery disease	2.26e-05	0.000423	CcSEcCtD
Candesartan—Vertigo—Lisinopril—coronary artery disease	2.25e-05	0.000421	CcSEcCtD
Candesartan—Vomiting—Eplerenone—coronary artery disease	2.24e-05	0.00042	CcSEcCtD
Candesartan—Leukopenia—Lisinopril—coronary artery disease	2.24e-05	0.000419	CcSEcCtD
Candesartan—Nausea—Fenofibrate—coronary artery disease	2.23e-05	0.000418	CcSEcCtD
Candesartan—Pruritus—Niacin—coronary artery disease	2.23e-05	0.000418	CcSEcCtD
Candesartan—Asthenia—Pravastatin—coronary artery disease	2.23e-05	0.000417	CcSEcCtD
Candesartan—Gastrointestinal pain—Furosemide—coronary artery disease	2.22e-05	0.000416	CcSEcCtD
Candesartan—Rash—Eplerenone—coronary artery disease	2.22e-05	0.000416	CcSEcCtD
Candesartan—Urticaria—Perindopril—coronary artery disease	2.22e-05	0.000416	CcSEcCtD
Candesartan—Dermatitis—Eplerenone—coronary artery disease	2.22e-05	0.000416	CcSEcCtD
Candesartan—Diarrhoea—Valsartan—coronary artery disease	2.22e-05	0.000416	CcSEcCtD
Candesartan—Abdominal pain—Perindopril—coronary artery disease	2.21e-05	0.000414	CcSEcCtD
Candesartan—Body temperature increased—Perindopril—coronary artery disease	2.21e-05	0.000414	CcSEcCtD
Candesartan—Palpitations—Lisinopril—coronary artery disease	2.21e-05	0.000414	CcSEcCtD
Candesartan—Diarrhoea—Olmesartan—coronary artery disease	2.21e-05	0.000414	CcSEcCtD
Candesartan—Headache—Eplerenone—coronary artery disease	2.21e-05	0.000414	CcSEcCtD
Candesartan—Thrombocytopenia—Ramipril—coronary artery disease	2.2e-05	0.000412	CcSEcCtD
Candesartan—Pruritus—Pravastatin—coronary artery disease	2.2e-05	0.000411	CcSEcCtD
Candesartan—Nausea—Clopidogrel—coronary artery disease	2.2e-05	0.000411	CcSEcCtD
Candesartan—Tachycardia—Ramipril—coronary artery disease	2.2e-05	0.000411	CcSEcCtD
Candesartan—Vomiting—Simvastatin—coronary artery disease	2.18e-05	0.000409	CcSEcCtD
Candesartan—Cough—Lisinopril—coronary artery disease	2.18e-05	0.000408	CcSEcCtD
Candesartan—Nausea—Lovastatin—coronary artery disease	2.18e-05	0.000408	CcSEcCtD
Candesartan—Hyperhidrosis—Ramipril—coronary artery disease	2.18e-05	0.000407	CcSEcCtD
Candesartan—Rash—Simvastatin—coronary artery disease	2.17e-05	0.000406	CcSEcCtD
Candesartan—Dermatitis—Simvastatin—coronary artery disease	2.16e-05	0.000405	CcSEcCtD
Candesartan—Asthenia—Trandolapril—coronary artery disease	2.16e-05	0.000405	CcSEcCtD
Candesartan—Urticaria—Furosemide—coronary artery disease	2.16e-05	0.000404	CcSEcCtD
Candesartan—Diarrhoea—Niacin—coronary artery disease	2.16e-05	0.000404	CcSEcCtD
Candesartan—Asthenia—Enalapril—coronary artery disease	2.16e-05	0.000404	CcSEcCtD
Candesartan—Headache—Simvastatin—coronary artery disease	2.15e-05	0.000403	CcSEcCtD
Candesartan—Body temperature increased—Furosemide—coronary artery disease	2.15e-05	0.000402	CcSEcCtD
Candesartan—Abdominal pain—Furosemide—coronary artery disease	2.15e-05	0.000402	CcSEcCtD
Candesartan—Gastrointestinal pain—Losartan—coronary artery disease	2.15e-05	0.000402	CcSEcCtD
Candesartan—Dizziness—Valsartan—coronary artery disease	2.15e-05	0.000402	CcSEcCtD
Candesartan—Nausea—Ezetimibe—coronary artery disease	2.14e-05	0.000401	CcSEcCtD
Candesartan—Dizziness—Olmesartan—coronary artery disease	2.14e-05	0.0004	CcSEcCtD
Candesartan—Pruritus—Trandolapril—coronary artery disease	2.13e-05	0.0004	CcSEcCtD
Candesartan—Myalgia—Lisinopril—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Arthralgia—Lisinopril—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Chest pain—Lisinopril—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Hyperhidrosis—Timolol—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Asthenia—Telmisartan—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Pruritus—Enalapril—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Diarrhoea—Pravastatin—coronary artery disease	2.13e-05	0.000398	CcSEcCtD
Candesartan—Anxiety—Lisinopril—coronary artery disease	2.12e-05	0.000397	CcSEcCtD
Candesartan—Hypotension—Ramipril—coronary artery disease	2.1e-05	0.000394	CcSEcCtD
Candesartan—Pruritus—Telmisartan—coronary artery disease	2.1e-05	0.000392	CcSEcCtD
Candesartan—Nausea—Eplerenone—coronary artery disease	2.09e-05	0.000392	CcSEcCtD
Candesartan—Dizziness—Niacin—coronary artery disease	2.09e-05	0.000391	CcSEcCtD
Candesartan—Urticaria—Losartan—coronary artery disease	2.08e-05	0.00039	CcSEcCtD
Candesartan—Abdominal pain—Losartan—coronary artery disease	2.07e-05	0.000388	CcSEcCtD
Candesartan—Body temperature increased—Losartan—coronary artery disease	2.07e-05	0.000388	CcSEcCtD
Candesartan—Asthenia—Captopril—coronary artery disease	2.07e-05	0.000387	CcSEcCtD
Candesartan—Diarrhoea—Trandolapril—coronary artery disease	2.06e-05	0.000386	CcSEcCtD
Candesartan—Vomiting—Valsartan—coronary artery disease	2.06e-05	0.000386	CcSEcCtD
Candesartan—Diarrhoea—Enalapril—coronary artery disease	2.06e-05	0.000385	CcSEcCtD
Candesartan—Hypotension—Timolol—coronary artery disease	2.06e-05	0.000385	CcSEcCtD
Candesartan—Dizziness—Pravastatin—coronary artery disease	2.05e-05	0.000385	CcSEcCtD
Candesartan—Vomiting—Olmesartan—coronary artery disease	2.05e-05	0.000384	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.05e-05	0.000384	CcSEcCtD
Candesartan—Rash—Valsartan—coronary artery disease	2.05e-05	0.000383	CcSEcCtD
Candesartan—Dermatitis—Valsartan—coronary artery disease	2.04e-05	0.000383	CcSEcCtD
Candesartan—Nausea—Simvastatin—coronary artery disease	2.04e-05	0.000382	CcSEcCtD
Candesartan—Pruritus—Captopril—coronary artery disease	2.04e-05	0.000382	CcSEcCtD
Candesartan—Rash—Olmesartan—coronary artery disease	2.04e-05	0.000381	CcSEcCtD
Candesartan—Dermatitis—Olmesartan—coronary artery disease	2.03e-05	0.000381	CcSEcCtD
Candesartan—Headache—Valsartan—coronary artery disease	2.03e-05	0.000381	CcSEcCtD
Candesartan—Diarrhoea—Telmisartan—coronary artery disease	2.03e-05	0.00038	CcSEcCtD
Candesartan—Headache—Olmesartan—coronary artery disease	2.02e-05	0.000379	CcSEcCtD
Candesartan—Paraesthesia—Ramipril—coronary artery disease	2.02e-05	0.000378	CcSEcCtD
Candesartan—Asthenia—Perindopril—coronary artery disease	2.01e-05	0.000376	CcSEcCtD
Candesartan—Dyspnoea—Ramipril—coronary artery disease	2.01e-05	0.000376	CcSEcCtD
Candesartan—Vomiting—Niacin—coronary artery disease	2.01e-05	0.000375	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Timolol—coronary artery disease	2e-05	0.000375	CcSEcCtD
Candesartan—Somnolence—Ramipril—coronary artery disease	2e-05	0.000374	CcSEcCtD
Candesartan—Thrombocytopenia—Lisinopril—coronary artery disease	2e-05	0.000374	CcSEcCtD
Candesartan—Dizziness—Trandolapril—coronary artery disease	1.99e-05	0.000373	CcSEcCtD
Candesartan—Tachycardia—Lisinopril—coronary artery disease	1.99e-05	0.000373	CcSEcCtD
Candesartan—Rash—Niacin—coronary artery disease	1.99e-05	0.000372	CcSEcCtD
Candesartan—Dermatitis—Niacin—coronary artery disease	1.99e-05	0.000372	CcSEcCtD
Candesartan—Dizziness—Enalapril—coronary artery disease	1.99e-05	0.000372	CcSEcCtD
Candesartan—Dyspepsia—Ramipril—coronary artery disease	1.98e-05	0.000371	CcSEcCtD
Candesartan—Pruritus—Perindopril—coronary artery disease	1.98e-05	0.000371	CcSEcCtD
Candesartan—Headache—Niacin—coronary artery disease	1.98e-05	0.00037	CcSEcCtD
Candesartan—Paraesthesia—Timolol—coronary artery disease	1.98e-05	0.00037	CcSEcCtD
Candesartan—Vomiting—Pravastatin—coronary artery disease	1.98e-05	0.00037	CcSEcCtD
Candesartan—Hyperhidrosis—Lisinopril—coronary artery disease	1.97e-05	0.000369	CcSEcCtD
Candesartan—Diarrhoea—Captopril—coronary artery disease	1.97e-05	0.000369	CcSEcCtD
Candesartan—Dyspnoea—Timolol—coronary artery disease	1.96e-05	0.000367	CcSEcCtD
Candesartan—Dizziness—Telmisartan—coronary artery disease	1.96e-05	0.000367	CcSEcCtD
Candesartan—Rash—Pravastatin—coronary artery disease	1.96e-05	0.000367	CcSEcCtD
Candesartan—Dermatitis—Pravastatin—coronary artery disease	1.96e-05	0.000366	CcSEcCtD
Candesartan—Somnolence—Timolol—coronary artery disease	1.96e-05	0.000366	CcSEcCtD
Candesartan—Asthenia—Furosemide—coronary artery disease	1.95e-05	0.000365	CcSEcCtD
Candesartan—Headache—Pravastatin—coronary artery disease	1.95e-05	0.000364	CcSEcCtD
Candesartan—Gastrointestinal disorder—Ramipril—coronary artery disease	1.94e-05	0.000364	CcSEcCtD
Candesartan—Fatigue—Ramipril—coronary artery disease	1.94e-05	0.000363	CcSEcCtD
Candesartan—Dyspepsia—Timolol—coronary artery disease	1.94e-05	0.000362	CcSEcCtD
Candesartan—Nausea—Valsartan—coronary artery disease	1.93e-05	0.000361	CcSEcCtD
Candesartan—Pruritus—Furosemide—coronary artery disease	1.92e-05	0.00036	CcSEcCtD
Candesartan—Nausea—Olmesartan—coronary artery disease	1.92e-05	0.000359	CcSEcCtD
Candesartan—Vomiting—Trandolapril—coronary artery disease	1.92e-05	0.000359	CcSEcCtD
Candesartan—Diarrhoea—Perindopril—coronary artery disease	1.91e-05	0.000358	CcSEcCtD
Candesartan—Vomiting—Enalapril—coronary artery disease	1.91e-05	0.000358	CcSEcCtD
Candesartan—Hypotension—Lisinopril—coronary artery disease	1.91e-05	0.000357	CcSEcCtD
Candesartan—Dizziness—Captopril—coronary artery disease	1.91e-05	0.000357	CcSEcCtD
Candesartan—Rash—Trandolapril—coronary artery disease	1.9e-05	0.000356	CcSEcCtD
Candesartan—Dermatitis—Trandolapril—coronary artery disease	1.9e-05	0.000356	CcSEcCtD
Candesartan—Gastrointestinal disorder—Timolol—coronary artery disease	1.9e-05	0.000356	CcSEcCtD
Candesartan—Fatigue—Timolol—coronary artery disease	1.9e-05	0.000355	CcSEcCtD
Candesartan—Rash—Enalapril—coronary artery disease	1.89e-05	0.000355	CcSEcCtD
Candesartan—Dermatitis—Enalapril—coronary artery disease	1.89e-05	0.000354	CcSEcCtD
Candesartan—Headache—Trandolapril—coronary artery disease	1.89e-05	0.000354	CcSEcCtD
Candesartan—Vomiting—Telmisartan—coronary artery disease	1.88e-05	0.000353	CcSEcCtD
Candesartan—Asthenia—Losartan—coronary artery disease	1.88e-05	0.000352	CcSEcCtD
Candesartan—Headache—Enalapril—coronary artery disease	1.88e-05	0.000352	CcSEcCtD
Candesartan—Nausea—Niacin—coronary artery disease	1.87e-05	0.000351	CcSEcCtD
Candesartan—Rash—Telmisartan—coronary artery disease	1.87e-05	0.00035	CcSEcCtD
Candesartan—Dermatitis—Telmisartan—coronary artery disease	1.87e-05	0.000349	CcSEcCtD
Candesartan—Diarrhoea—Furosemide—coronary artery disease	1.86e-05	0.000348	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.86e-05	0.000348	CcSEcCtD
Candesartan—Pruritus—Losartan—coronary artery disease	1.86e-05	0.000348	CcSEcCtD
Candesartan—Headache—Telmisartan—coronary artery disease	1.86e-05	0.000348	CcSEcCtD
Candesartan—Dizziness—Perindopril—coronary artery disease	1.85e-05	0.000346	CcSEcCtD
Candesartan—Nausea—Pravastatin—coronary artery disease	1.85e-05	0.000345	CcSEcCtD
Candesartan—Gastrointestinal pain—Ramipril—coronary artery disease	1.84e-05	0.000344	CcSEcCtD
Candesartan—Paraesthesia—Lisinopril—coronary artery disease	1.83e-05	0.000343	CcSEcCtD
Candesartan—Vomiting—Captopril—coronary artery disease	1.83e-05	0.000343	CcSEcCtD
Candesartan—Dyspnoea—Lisinopril—coronary artery disease	1.82e-05	0.000341	CcSEcCtD
Candesartan—Rash—Captopril—coronary artery disease	1.82e-05	0.00034	CcSEcCtD
Candesartan—Dermatitis—Captopril—coronary artery disease	1.82e-05	0.00034	CcSEcCtD
Candesartan—Somnolence—Lisinopril—coronary artery disease	1.81e-05	0.00034	CcSEcCtD
Candesartan—Headache—Captopril—coronary artery disease	1.81e-05	0.000338	CcSEcCtD
Candesartan—Gastrointestinal pain—Timolol—coronary artery disease	1.8e-05	0.000337	CcSEcCtD
Candesartan—Dizziness—Furosemide—coronary artery disease	1.8e-05	0.000337	CcSEcCtD
Candesartan—Dyspepsia—Lisinopril—coronary artery disease	1.8e-05	0.000336	CcSEcCtD
Candesartan—Diarrhoea—Losartan—coronary artery disease	1.8e-05	0.000336	CcSEcCtD
Candesartan—Nausea—Trandolapril—coronary artery disease	1.79e-05	0.000335	CcSEcCtD
Candesartan—Urticaria—Ramipril—coronary artery disease	1.79e-05	0.000335	CcSEcCtD
Candesartan—Nausea—Enalapril—coronary artery disease	1.78e-05	0.000334	CcSEcCtD
Candesartan—Vomiting—Perindopril—coronary artery disease	1.78e-05	0.000333	CcSEcCtD
Candesartan—Abdominal pain—Ramipril—coronary artery disease	1.78e-05	0.000333	CcSEcCtD
Candesartan—Body temperature increased—Ramipril—coronary artery disease	1.78e-05	0.000333	CcSEcCtD
Candesartan—Rash—Perindopril—coronary artery disease	1.76e-05	0.00033	CcSEcCtD
Candesartan—Dermatitis—Perindopril—coronary artery disease	1.76e-05	0.00033	CcSEcCtD
Candesartan—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.76e-05	0.00033	CcSEcCtD
Candesartan—Nausea—Telmisartan—coronary artery disease	1.76e-05	0.000329	CcSEcCtD
Candesartan—Fatigue—Lisinopril—coronary artery disease	1.76e-05	0.000329	CcSEcCtD
Candesartan—Headache—Perindopril—coronary artery disease	1.75e-05	0.000328	CcSEcCtD
Candesartan—Urticaria—Timolol—coronary artery disease	1.75e-05	0.000327	CcSEcCtD
Candesartan—Abdominal pain—Timolol—coronary artery disease	1.74e-05	0.000326	CcSEcCtD
Candesartan—Body temperature increased—Timolol—coronary artery disease	1.74e-05	0.000326	CcSEcCtD
Candesartan—Dizziness—Losartan—coronary artery disease	1.74e-05	0.000325	CcSEcCtD
Candesartan—Vomiting—Furosemide—coronary artery disease	1.73e-05	0.000324	CcSEcCtD
Candesartan—Rash—Furosemide—coronary artery disease	1.71e-05	0.000321	CcSEcCtD
Candesartan—Dermatitis—Furosemide—coronary artery disease	1.71e-05	0.000321	CcSEcCtD
Candesartan—Nausea—Captopril—coronary artery disease	1.71e-05	0.00032	CcSEcCtD
Candesartan—Headache—Furosemide—coronary artery disease	1.7e-05	0.000319	CcSEcCtD
Candesartan—Gastrointestinal pain—Lisinopril—coronary artery disease	1.67e-05	0.000312	CcSEcCtD
Candesartan—Vomiting—Losartan—coronary artery disease	1.67e-05	0.000312	CcSEcCtD
Candesartan—Nausea—Perindopril—coronary artery disease	1.66e-05	0.000311	CcSEcCtD
Candesartan—Rash—Losartan—coronary artery disease	1.65e-05	0.00031	CcSEcCtD
Candesartan—Dermatitis—Losartan—coronary artery disease	1.65e-05	0.000309	CcSEcCtD
Candesartan—Headache—Losartan—coronary artery disease	1.64e-05	0.000308	CcSEcCtD
Candesartan—Urticaria—Lisinopril—coronary artery disease	1.62e-05	0.000303	CcSEcCtD
Candesartan—Nausea—Furosemide—coronary artery disease	1.62e-05	0.000302	CcSEcCtD
Candesartan—Asthenia—Ramipril—coronary artery disease	1.61e-05	0.000302	CcSEcCtD
Candesartan—Abdominal pain—Lisinopril—coronary artery disease	1.61e-05	0.000302	CcSEcCtD
Candesartan—Body temperature increased—Lisinopril—coronary artery disease	1.61e-05	0.000302	CcSEcCtD
Candesartan—Pruritus—Ramipril—coronary artery disease	1.59e-05	0.000298	CcSEcCtD
Candesartan—Asthenia—Timolol—coronary artery disease	1.58e-05	0.000295	CcSEcCtD
Candesartan—Nausea—Losartan—coronary artery disease	1.56e-05	0.000292	CcSEcCtD
Candesartan—Pruritus—Timolol—coronary artery disease	1.56e-05	0.000291	CcSEcCtD
Candesartan—Diarrhoea—Ramipril—coronary artery disease	1.54e-05	0.000288	CcSEcCtD
Candesartan—Diarrhoea—Timolol—coronary artery disease	1.51e-05	0.000282	CcSEcCtD
Candesartan—Dizziness—Ramipril—coronary artery disease	1.49e-05	0.000279	CcSEcCtD
Candesartan—Asthenia—Lisinopril—coronary artery disease	1.46e-05	0.000274	CcSEcCtD
Candesartan—Dizziness—Timolol—coronary artery disease	1.45e-05	0.000272	CcSEcCtD
Candesartan—Pruritus—Lisinopril—coronary artery disease	1.44e-05	0.00027	CcSEcCtD
Candesartan—Vomiting—Ramipril—coronary artery disease	1.43e-05	0.000268	CcSEcCtD
Candesartan—Rash—Ramipril—coronary artery disease	1.42e-05	0.000266	CcSEcCtD
Candesartan—Dermatitis—Ramipril—coronary artery disease	1.42e-05	0.000265	CcSEcCtD
Candesartan—Headache—Ramipril—coronary artery disease	1.41e-05	0.000264	CcSEcCtD
Candesartan—Vomiting—Timolol—coronary artery disease	1.4e-05	0.000262	CcSEcCtD
Candesartan—Diarrhoea—Lisinopril—coronary artery disease	1.4e-05	0.000261	CcSEcCtD
Candesartan—Rash—Timolol—coronary artery disease	1.39e-05	0.00026	CcSEcCtD
Candesartan—Dermatitis—Timolol—coronary artery disease	1.39e-05	0.000259	CcSEcCtD
Candesartan—Headache—Timolol—coronary artery disease	1.38e-05	0.000258	CcSEcCtD
Candesartan—Dizziness—Lisinopril—coronary artery disease	1.35e-05	0.000253	CcSEcCtD
Candesartan—Nausea—Ramipril—coronary artery disease	1.34e-05	0.00025	CcSEcCtD
Candesartan—Losartan—ALB—coronary artery disease	1.32e-05	0.00895	CrCbGaD
Candesartan—Nausea—Timolol—coronary artery disease	1.31e-05	0.000245	CcSEcCtD
Candesartan—Vomiting—Lisinopril—coronary artery disease	1.3e-05	0.000243	CcSEcCtD
Candesartan—Rash—Lisinopril—coronary artery disease	1.29e-05	0.000241	CcSEcCtD
Candesartan—Dermatitis—Lisinopril—coronary artery disease	1.29e-05	0.000241	CcSEcCtD
Candesartan—Headache—Lisinopril—coronary artery disease	1.28e-05	0.000239	CcSEcCtD
Candesartan—Nausea—Lisinopril—coronary artery disease	1.21e-05	0.000227	CcSEcCtD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.16e-06	8.45e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TXNRD1—coronary artery disease	2.16e-06	8.45e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP11B2—coronary artery disease	2.16e-06	8.45e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GGT1—coronary artery disease	2.15e-06	8.44e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GOT1—coronary artery disease	2.15e-06	8.44e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	2.15e-06	8.43e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	2.15e-06	8.41e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA2—coronary artery disease	2.12e-06	8.32e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G2A—coronary artery disease	2.12e-06	8.32e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX2—coronary artery disease	2.12e-06	8.32e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC22A3—coronary artery disease	2.12e-06	8.32e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.12e-06	8.31e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KIT—coronary artery disease	2.12e-06	8.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX4—coronary artery disease	2.1e-06	8.22e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCG5—coronary artery disease	2.1e-06	8.22e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SULT1A1—coronary artery disease	2.1e-06	8.22e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HK1—coronary artery disease	2.1e-06	8.22e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.1e-06	8.22e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ARNTL—coronary artery disease	2.09e-06	8.2e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HADH—coronary artery disease	2.09e-06	8.2e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HADHA—coronary artery disease	2.07e-06	8.12e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.06e-06	8.07e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTA1—coronary artery disease	2.05e-06	8.03e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	2.05e-06	8.02e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—coronary artery disease	2.03e-06	7.97e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GSK3B—coronary artery disease	2.03e-06	7.96e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPA—coronary artery disease	2.03e-06	7.94e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—VCAN—coronary artery disease	2.02e-06	7.93e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CREB1—coronary artery disease	2.02e-06	7.9e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—coronary artery disease	2.02e-06	7.9e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.01e-06	7.88e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDOA—coronary artery disease	2.01e-06	7.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	1.98e-06	7.77e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX2—coronary artery disease	1.98e-06	7.77e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA2—coronary artery disease	1.98e-06	7.77e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—coronary artery disease	1.97e-06	7.73e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6R—coronary artery disease	1.97e-06	7.7e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLCB3—coronary artery disease	1.96e-06	7.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HK1—coronary artery disease	1.96e-06	7.68e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SULT1A1—coronary artery disease	1.96e-06	7.68e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCG5—coronary artery disease	1.96e-06	7.68e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX4—coronary artery disease	1.96e-06	7.68e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.96e-06	7.67e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—DCN—coronary artery disease	1.95e-06	7.64e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—coronary artery disease	1.95e-06	7.62e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA5—coronary artery disease	1.94e-06	7.61e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—coronary artery disease	1.94e-06	7.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HADHA—coronary artery disease	1.94e-06	7.59e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—coronary artery disease	1.93e-06	7.58e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK1—coronary artery disease	1.93e-06	7.56e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARGC1A—coronary artery disease	1.92e-06	7.51e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTA1—coronary artery disease	1.91e-06	7.5e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—coronary artery disease	1.91e-06	7.48e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—P4HB—coronary artery disease	1.9e-06	7.46e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDH2—coronary artery disease	1.9e-06	7.43e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPA—coronary artery disease	1.89e-06	7.42e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAT—coronary artery disease	1.88e-06	7.38e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G1B—coronary artery disease	1.87e-06	7.33e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.87e-06	7.31e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.85e-06	7.24e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HBA1—coronary artery disease	1.85e-06	7.24e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—coronary artery disease	1.85e-06	7.24e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	1.85e-06	7.24e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2C19—coronary artery disease	1.85e-06	7.24e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.84e-06	7.22e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—coronary artery disease	1.84e-06	7.21e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOC3—coronary artery disease	1.84e-06	7.19e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLCB3—coronary artery disease	1.83e-06	7.18e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOB—coronary artery disease	1.83e-06	7.16e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LDLR—coronary artery disease	1.82e-06	7.15e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.82e-06	7.14e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA5—coronary artery disease	1.81e-06	7.11e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—coronary artery disease	1.8e-06	7.07e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC9A1—coronary artery disease	1.8e-06	7.07e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCLC—coronary artery disease	1.78e-06	6.98e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CETP—coronary artery disease	1.78e-06	6.98e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGF2—coronary artery disease	1.78e-06	6.98e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—coronary artery disease	1.78e-06	6.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—P4HB—coronary artery disease	1.78e-06	6.97e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—coronary artery disease	1.78e-06	6.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.76e-06	6.91e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—VCAN—coronary artery disease	1.76e-06	6.91e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDC1—coronary artery disease	1.76e-06	6.91e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—coronary artery disease	1.76e-06	6.89e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDOA—coronary artery disease	1.75e-06	6.85e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.75e-06	6.84e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—coronary artery disease	1.75e-06	6.84e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.74e-06	6.81e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.73e-06	6.77e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAK2—coronary artery disease	1.71e-06	6.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.71e-06	6.69e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—coronary artery disease	1.7e-06	6.67e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DCN—coronary artery disease	1.7e-06	6.65e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—coronary artery disease	1.67e-06	6.56e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMB5—coronary artery disease	1.67e-06	6.52e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMA6—coronary artery disease	1.67e-06	6.52e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.66e-06	6.51e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—coronary artery disease	1.66e-06	6.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDH2—coronary artery disease	1.65e-06	6.47e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—VCAN—coronary artery disease	1.65e-06	6.45e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPP2CA—coronary artery disease	1.64e-06	6.42e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.63e-06	6.4e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CTGF—coronary artery disease	1.63e-06	6.37e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.61e-06	6.32e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT2—coronary artery disease	1.61e-06	6.32e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—coronary artery disease	1.61e-06	6.31e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HBA1—coronary artery disease	1.61e-06	6.31e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2C19—coronary artery disease	1.61e-06	6.31e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3C2A—coronary artery disease	1.61e-06	6.31e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOC3—coronary artery disease	1.6e-06	6.27e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LDLR—coronary artery disease	1.59e-06	6.23e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DCN—coronary artery disease	1.59e-06	6.21e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—coronary artery disease	1.57e-06	6.16e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—coronary artery disease	1.57e-06	6.16e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC9A1—coronary artery disease	1.57e-06	6.16e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—coronary artery disease	1.56e-06	6.11e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCLC—coronary artery disease	1.55e-06	6.08e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CETP—coronary artery disease	1.55e-06	6.08e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.54e-06	6.05e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDC1—coronary artery disease	1.54e-06	6.02e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.52e-06	5.97e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—coronary artery disease	1.51e-06	5.9e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HBA1—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOC3—coronary artery disease	1.49e-06	5.86e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—coronary artery disease	1.49e-06	5.85e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—coronary artery disease	1.49e-06	5.85e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LDLR—coronary artery disease	1.49e-06	5.82e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.48e-06	5.81e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.48e-06	5.81e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—coronary artery disease	1.48e-06	5.81e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.47e-06	5.75e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.47e-06	5.75e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—coronary artery disease	1.46e-06	5.73e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.45e-06	5.7e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—coronary artery disease	1.45e-06	5.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCLC—coronary artery disease	1.45e-06	5.68e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CETP—coronary artery disease	1.45e-06	5.68e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMB5—coronary artery disease	1.45e-06	5.68e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMA6—coronary artery disease	1.45e-06	5.68e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA1—coronary artery disease	1.45e-06	5.67e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.44e-06	5.63e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDC1—coronary artery disease	1.43e-06	5.62e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CTGF—coronary artery disease	1.42e-06	5.55e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—coronary artery disease	1.41e-06	5.52e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMGCR—coronary artery disease	1.4e-06	5.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT2—coronary artery disease	1.4e-06	5.5e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GGT1—coronary artery disease	1.39e-06	5.45e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT1—coronary artery disease	1.39e-06	5.45e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.38e-06	5.43e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.38e-06	5.39e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—coronary artery disease	1.37e-06	5.36e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.36e-06	5.31e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.36e-06	5.31e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.35e-06	5.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CTGF—coronary artery disease	1.32e-06	5.19e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.31e-06	5.14e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT2—coronary artery disease	1.31e-06	5.14e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLCB1—coronary artery disease	1.29e-06	5.06e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—coronary artery disease	1.27e-06	4.99e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—coronary artery disease	1.27e-06	4.96e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—coronary artery disease	1.26e-06	4.92e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCA1—coronary artery disease	1.25e-06	4.9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.25e-06	4.9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.24e-06	4.85e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.23e-06	4.83e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAT—coronary artery disease	1.22e-06	4.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT1—coronary artery disease	1.21e-06	4.75e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GGT1—coronary artery disease	1.21e-06	4.75e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.21e-06	4.73e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.18e-06	4.64e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOB—coronary artery disease	1.18e-06	4.63e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.17e-06	4.58e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—coronary artery disease	1.16e-06	4.55e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.15e-06	4.5e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—coronary artery disease	1.15e-06	4.49e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK1—coronary artery disease	1.14e-06	4.47e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GGT1—coronary artery disease	1.13e-06	4.44e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT1—coronary artery disease	1.13e-06	4.44e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—coronary artery disease	1.13e-06	4.42e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—coronary artery disease	1.1e-06	4.31e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—coronary artery disease	1.1e-06	4.29e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—coronary artery disease	1.09e-06	4.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—coronary artery disease	1.09e-06	4.27e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.08e-06	4.23e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—coronary artery disease	1.07e-06	4.21e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—coronary artery disease	1.07e-06	4.2e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAT—coronary artery disease	1.06e-06	4.15e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.06e-06	4.14e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOB—coronary artery disease	1.03e-06	4.03e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.02e-06	3.99e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.02e-06	3.98e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.01e-06	3.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—coronary artery disease	1e-06	3.93e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—coronary artery disease	1e-06	3.93e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—coronary artery disease	1e-06	3.92e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAT—coronary artery disease	9.9e-07	3.88e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—coronary artery disease	9.89e-07	3.87e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—coronary artery disease	9.82e-07	3.85e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—coronary artery disease	9.64e-07	3.78e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOB—coronary artery disease	9.61e-07	3.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—coronary artery disease	9.58e-07	3.75e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—coronary artery disease	9.45e-07	3.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—coronary artery disease	9.35e-07	3.66e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA1—coronary artery disease	9.34e-07	3.66e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—coronary artery disease	9.33e-07	3.66e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPP2CA—coronary artery disease	9.22e-07	3.61e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—coronary artery disease	9.18e-07	3.6e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—coronary artery disease	8.95e-07	3.51e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.95e-07	3.51e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—coronary artery disease	8.95e-07	3.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—coronary artery disease	8.84e-07	3.47e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—coronary artery disease	8.76e-07	3.43e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—coronary artery disease	8.72e-07	3.42e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPP2CA—coronary artery disease	8.61e-07	3.37e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—coronary artery disease	8.4e-07	3.29e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—coronary artery disease	8.26e-07	3.24e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—coronary artery disease	8.23e-07	3.23e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—coronary artery disease	8.23e-07	3.23e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA1—coronary artery disease	8.14e-07	3.19e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—coronary artery disease	8.12e-07	3.18e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—coronary artery disease	8.08e-07	3.17e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—coronary artery disease	7.85e-07	3.08e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—coronary artery disease	7.69e-07	3.01e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA1—coronary artery disease	7.6e-07	2.98e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—coronary artery disease	7.4e-07	2.9e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.28e-07	2.85e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—coronary artery disease	7.17e-07	2.81e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—coronary artery disease	7.08e-07	2.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—coronary artery disease	7.07e-07	2.77e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—coronary artery disease	6.7e-07	2.62e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—coronary artery disease	6.61e-07	2.59e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—coronary artery disease	6.48e-07	2.54e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—coronary artery disease	6.45e-07	2.53e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—coronary artery disease	6.17e-07	2.42e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—coronary artery disease	6.17e-07	2.42e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—coronary artery disease	6.02e-07	2.36e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—coronary artery disease	5.76e-07	2.26e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—coronary artery disease	5.64e-07	2.21e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.27e-07	2.06e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—coronary artery disease	5.04e-07	1.97e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—coronary artery disease	3.98e-07	1.56e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.47e-07	1.36e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—coronary artery disease	3.25e-07	1.28e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.24e-07	1.27e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—coronary artery disease	2.84e-07	1.11e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—coronary artery disease	2.65e-07	1.04e-05	CbGpPWpGaD
